Portfolio Concentration Risk: Why I Underwrite the Shape of the Book

Concentration is the risk that quietly does the damage.

I put short-term capital into many small businesses and am repaid out of their daily sales. On its surface the model is simple, and the instinct is to judge it one deal at a time. Is this business sound? Will it repay? Those are fair questions for a single position. They are the wrong frame for the thing I actually hold, which is a book. The property that most determines how that book behaves is portfolio concentration risk, and it is the exposure I watch before almost anything else.

Why Portfolio Concentration Risk Hides in Plain Sight

Concentration is the risk that quietly does the damage. It never shows up in any single underwriting decision. Every position can look reasonable on its own while the book as a whole carries a fragility that none of them reveals individually. The exposure lives in the distribution, not in the deal, which is precisely why it gets underweighted. Underwriting attention naturally goes to the file in front of you, and concentration is invisible at that level.

Consider two books of the same total size. One is built from many small positions. The other from a handful of large ones. They are not two versions of the same risk. They are different instruments. When one business stumbles in the first book, it is immaterial, lost in the aggregate. When one business stumbles in the second, it leaves a mark I can measure. Same event, two entirely different outcomes, decided by how the capital was distributed.

Put plainly, I can lose one position out of a hundred and the book absorbs it. Lose one out of ten and I feel it. The arithmetic is obvious once it is stated, and yet it is routinely set aside in favor of deal-level conviction.

This is why I treat the questions that matter as structural ones. How many positions. How large is the largest relative to the total. How correlated are the names, by industry, by geography, by the conditions that would pressure them at the same time. A book can be full of sound individual deals and still be poorly built. A book of more ordinary deals, well distributed, can be far more durable.

I still read each business honestly. That work matters. But it sits inside a larger discipline, and the larger discipline is portfolio construction. In the end I am not underwriting individual businesses so much as the shape they make together.

Private Credit Is Not One Thing: What I See Inside the Commercial Receivables Lane

Private credit is not one category. Direct lending sits at three to seven year corporate credit duration. Short duration commercial receivables under UCC Article 9 sits at ninety to one hundred eighty day asset purchase duration. Ali Barkhordar operates in the specialty finance corner of the category out of Sheridan Wyoming.

When an allocator tells me they hold private credit, the picture in their head is almost always the same. A direct lending fund. Senior secured loans to middle market companies. Sponsor backed. Three to seven year terms. Quarterly distributions. That is the dominant strategy in the category and it is where most of the institutional and high net worth capital has flowed over the last decade.

It is also one slice of a much larger category. I work a different slice.

Private credit covers everything from senior corporate loans to asset backed strategies that look almost nothing like a loan. Mezzanine. Distressed. Real estate debt. Specialty finance. The label is the same across all of them. The underlying exposure is not.

The lane I work every day is short duration commercial receivables. It sits inside the specialty finance corner of private credit. I run it out of Sheridan Wyoming under Ultimate Business Capital. It is private credit by category. By mechanics it is a different instrument entirely from direct lending.

What I Watch For Inside the Private Credit Commercial Receivables Lane

Three concrete differences separate what I do from a direct lending fund.

Duration. A direct lending fund holds three to seven year paper. The receivables I work with run ninety to one hundred eighty days. That is not a small variation. Duration drives volatility, drives reinvestment cadence, drives how a position behaves through a credit cycle. The shorter cadence changes the entire operational rhythm of the strategy.

Collateral. Direct lending is collateralized by the enterprise value of an operating company. The lender holds a claim against the business as a going concern. The receivables I work with are collateralized by the receivable itself. I am not betting on the long term equity story of the business. I am holding a specifically identified asset.

Legal framework. Direct lending is a creditor relationship documented through a loan agreement. The work I do is documented as a purchase under UCC Article 9. Ownership of the receivable transfers from seller to buyer, and the position is established by a filing of record on the public Secretary of State database. This is not a lending transaction. It is an asset acquisition.

An allocator who already holds direct lending is holding three to seven year senior corporate credit at the top of an operating company capital stack. That allocator is not holding ninety to one hundred eighty day asset backed cashflow positions acquired through direct UCC Article 9 purchase. Both sit under the private credit umbrella. The characteristics do not overlap meaningfully.

When I look at how most allocators have built their private credit sleeve, I see direct lending and not much else. The category label is the starting point. The sub category is where the actual exposure lives. The mechanics determine what is actually being held.

The question I ask the allocators I talk to is not whether they own private credit. It is which slices of it they own, and which slices they have left uncovered. I work one of the uncovered slices.

Cash Flow Financing Is Not a Bank Loan | Ali Barkhordar

I have reviewed both documents. One is a promissory note. The other is a purchase agreement recorded under Wyoming law. They are not two versions of the same instrument.

Cash Flow Financing Is Not a Bank Loan

Every week I see the same assumption repeated in conversation, in the press, and in the way buyers evaluate this asset class: the business used cash flow financing because a bank turned them down. I have been in this market long enough to know that framing is wrong more often than it is correct.

The bank did not decline them. The bank does not offer this product. Those are two different statements and the distinction matters at the level of the operative legal document.

The Document I Work With Is Not a Promissory Note

When I source a commercial receivable, the transaction closes on a purchase agreement. Ownership of a specifically identified payment intangible transfers from seller to buyer under UCC Article 9. A perfected security interest is recorded on public record with the applicable Secretary of State. No debt obligation is created on the merchant side.

A bank produces a promissory note. The merchant owes a defined sum, payable on a defined schedule, to a creditor holding a claim against the merchant's capacity to repay.

These are not two versions of the same instrument. I have reviewed both documents. They are governed by different bodies of law and they produce different legal relationships between the parties.

The Underwriting Questions Are Different

When I evaluate a position, I am not asking whether this merchant can service a fixed obligation over a multi year amortization period. That is the bank's question. My question is whether the cashflow this business generates on a daily basis can support a forward without disrupting operations.

The relevant variables are bank statement performance, existing position count relative to demonstrated cashflow, negative balance frequency, and industry default patterns. None of those variables map cleanly onto a bank credit committee's underwriting checklist. They are not supposed to. They are answers to a different question.

The Cost Comparison People Make Is Invalid

I hear the factor rate versus APR comparison constantly. Comparing a factor rate to an annual percentage rate without adjusting for duration produces a figure that answers the wrong question.

A bank credit facility at 8% APR amortizes over years. A commercial receivable I source at a 1.35 factor turns in 90 days. Duration, origination timeline, collateral structure, and documentation requirements are all materially different across those two structures. Reducing that comparison to a single annualized cost figure discards every variable that determines whether either structure is appropriate for a given business at a given moment.

What I Actually See in Practice

The businesses that use cash flow financing are not failed bank applicants. They are businesses generating consistent, verifiable revenue that need capital on a timeline and under conditions the banking system is not structured to deliver. That is not a credit quality statement. It is a structural observation.

For the businesses this market serves, cash flow financing is the correct primary structure for their operating conditions. Calling it alternative implies substitution. I have never seen it operate that way.

About My Work

I am the Founder and CEO of Ultimate Business Capital LLC, a Wyoming entity headquartered in Sheridan, Wyoming. UBC sources whole commercial receivables for institutional buyers under UCC Article 9 direct assignment. All transactions are governed by Wyoming law.